Volume 43, Issue 3, Page 6 (March 2009)
7 of 23
PREVIEW
FULL TEXT
FULL-TEXT PDF (444 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
DOWNLOAD IMAGES
NEED REPRINTS?
BOOKMARK ARTICLE
ATLANTA — The human papillomavirus vaccine was efficacious in preventing persistent infections and genital warts caused by HPV strains 6, 11, 16, and 18 in a Merck-sponsored study of 4,065 males aged 16-26 years.
PII: S0031-398X(09)70069-4
doi:10.1016/S0031-398X(09)70069-4
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW